SwePub
Sök i LIBRIS databas

  Utökad sökning

id:"swepub:oai:lup.lub.lu.se:d96aeb07-0529-4397-b1fc-213e0c48252a"
 

Sökning: id:"swepub:oai:lup.lub.lu.se:d96aeb07-0529-4397-b1fc-213e0c48252a" > Clinical associatio...

  • Kronbichler, AndreasMedical University of Innsbruck,Addenbrooke's Hospital (författare)

Clinical associations with venous thromboembolism in anti-neutrophil cytoplasm antibody-associated vasculitides

  • Artikel/kapitelEngelska2017

Förlag, utgivningsår, omfång ...

  • 2017-01-03
  • Oxford University Press (OUP),2017
  • 5 s.

Nummerbeteckningar

  • LIBRIS-ID:oai:lup.lub.lu.se:d96aeb07-0529-4397-b1fc-213e0c48252a
  • https://lup.lub.lu.se/record/d96aeb07-0529-4397-b1fc-213e0c48252aURI
  • https://doi.org/10.1093/rheumatology/kew465DOI

Kompletterande språkuppgifter

  • Språk:engelska
  • Sammanfattning på:engelska

Ingår i deldatabas

Klassifikation

  • Ämneskategori:art swepub-publicationtype
  • Ämneskategori:ref swepub-contenttype

Anmärkningar

  • Objective. To assess potential associations for the development of venous thromboembolic events in patients with ANCA-associated vasculitides (AAV). Methods. Four hundred and seventeen patients enrolled to participate in randomized controlled trials conducted by the European Vasculitis Society were identified. Univariate and multivariate analyses were performed to validate previously proposed and identify novel risks associated with venous thromboembolism (VTE) in AAV. Results. VTE occurred in 41 of 417 (9.8%) patients. Uncorrected univariate analysis identified BVAS (odds ratio, OR= 1.05, 95% CI: 1.01, 1.10; P = 0.013), subsequent development of malignancy (OR = 2.6, 95% CI: 1.19, 5.71; P = 0.017), mucous membrane or eye involvement (OR = 2.13, 95% CI: 1.10, 4.11; P = 0.024) and baseline creatinine (OR = 1.08, 95% CI: 0.99, 1.18; P = 0.037) as being associated with the development of VTE. Multivariate analysis highlighted CRP (per 10 mg/l increase, OR= 1.05, 95% CI: 1.01, 1.09; P = 0.025), cutaneous involvement (OR = 4.83, 95% CI: 1.63, 14.38; P = 0.005) and gastrointestinal involvement (OR = 6.27, 95% CI: 1.34, 29.37; P = 0.02) among the BVAS items as well as baseline creatinine (per 100 mmol/l increase, OR= 1.17, 95% CI: 1.02, 1.35; P = 0.029) as being associated with VTEs. Conclusion. Our results highlight a role of CRP, baseline creatinine, and cutaneous and gastrointestinal involvement in the risk stratification as being associated with thromboembolic events. Moreover, there might be an association between VTEs and subsequent development of malignancy and disease activity in general.

Ämnesord och genrebeteckningar

Biuppslag (personer, institutioner, konferenser, titlar ...)

  • Leierer, JohannesMedical University of Innsbruck (författare)
  • Leierer, GiselaMedical University of Innsbruck (författare)
  • Mayer, GertMedical University of Innsbruck (författare)
  • Casian, AlinaGuy's and St Thomas' NHS Foundation Trust (författare)
  • Höglund, PeterLund University,Lunds universitet,Avdelningen för klinisk kemi och farmakologi,Institutionen för laboratoriemedicin,Medicinska fakulteten,Division of Clinical Chemistry and Pharmacology,Department of Laboratory Medicine,Faculty of Medicine,Skåne University Hospital(Swepub:lu)kfar-pho (författare)
  • Westman, KerstinLund University,Lunds universitet,Njurmedicin,Sektion II,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Autoimmunitet och njursjukdomar,Forskargrupper vid Lunds universitet,Nephrology,Section II,Department of Clinical Sciences, Lund,Faculty of Medicine,Autoimmunity and kidney diseases,Lund University Research Groups(Swepub:lu)njur-kwe (författare)
  • Jayne, DavidAddenbrooke's Hospital (författare)
  • Medical University of InnsbruckAddenbrooke's Hospital (creator_code:org_t)

Sammanhörande titlar

  • Ingår i:Rheumatology: Oxford University Press (OUP)56:5, s. 704-7081462-03241462-0332

Internetlänk

Hitta via bibliotek

Till lärosätets databas

Sök utanför SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy